Co-Diagnostics CODX Stock
Co-Diagnostics Price Chart
Co-Diagnostics CODX Financial and Trading Overview
| Co-Diagnostics stock price | 3.23 USD |
| Previous Close | 3.37 USD |
| Open | 3.23 USD |
| Bid | 2.4 USD x 200 |
| Ask | 3.21 USD x 100 |
| Day's Range | 3.11 - 3.32 USD |
| 52 Week Range | 1.26 - 46.5 USD |
| Volume | 170.56K USD |
| Avg. Volume | 5.74M USD |
| Market Cap | 11.5M USD |
| Beta (5Y Monthly) | 2.753 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -32.26 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CODX Valuation Measures
| Enterprise Value | 5.04M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.25999978 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 16.010475 |
| Price/Book (mrq) | 0.7006512 |
| Enterprise Value/Revenue | 7.017 |
| Enterprise Value/EBITDA | -0.163 |
Trading Information
Co-Diagnostics Stock Price History
| Beta (5Y Monthly) | 2.753 |
| 52-Week Change | -60.90% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 46.5 USD |
| 52 Week Low | 1.26 USD |
| 50-Day Moving Average | 3.26 USD |
| 200-Day Moving Average | 6.3 USD |
CODX Share Statistics
| Avg. Volume (3 month) | 5.74M USD |
| Avg. Daily Volume (10-Days) | 395.04K USD |
| Shares Outstanding | 3.69M |
| Float | 3.49M |
| Short Ratio | 0.02 |
| % Held by Insiders | 3.60% |
| % Held by Institutions | 9.52% |
| Shares Short | 349.39K |
| Short % of Float | 9.80% |
| Short % of Shares Outstanding | 9.47% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -6309.11% |
| Gross Margin | 45.06% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -52.088% |
| Return on Equity (ttm) | -151.65% |
Income Statement
| Revenue (ttm) | 718.17K USD |
| Revenue Per Share (ttm) | 0.44 USD |
| Quarterly Revenue Growth (yoy) | 190.30% |
| Gross Profit (ttm) | 323.61K USD |
| EBITDA | -30858000 USD |
| Net Income Avi to Common (ttm) | -48502704 USD |
| Diluted EPS (ttm) | -32.26 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.23M USD |
| Total Cash Per Share (mrq) | 2.29 USD |
| Total Debt (mrq) | 2.03M USD |
| Total Debt/Equity (mrq) | 12.66 USD |
| Current Ratio (mrq) | 2.283 |
| Book Value Per Share (mrq) | 4.453 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -28237988 USD |
| Levered Free Cash Flow (ttm) | -18284196 USD |
Profile of Co-Diagnostics
| Country | United States |
| State | UT |
| City | Salt Lake City |
| Address | 2401 S. Foothill Drive |
| ZIP | 84109 |
| Phone | 801 438 1036 |
| Website | https://co-dx.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 115 |
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Q&A For Co-Diagnostics Stock
What is a current CODX stock price?
Co-Diagnostics CODX stock price today per share is 3.23 USD.
How to purchase Co-Diagnostics stock?
You can buy CODX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Co-Diagnostics?
The stock symbol or ticker of Co-Diagnostics is CODX.
Which industry does the Co-Diagnostics company belong to?
The Co-Diagnostics industry is Medical Devices.
How many shares does Co-Diagnostics have in circulation?
The max supply of Co-Diagnostics shares is 3.66M.
What is Co-Diagnostics Price to Earnings Ratio (PE Ratio)?
Co-Diagnostics PE Ratio is now.
What was Co-Diagnostics earnings per share over the trailing 12 months (TTM)?
Co-Diagnostics EPS is -32.26 USD over the trailing 12 months.
Which sector does the Co-Diagnostics company belong to?
The Co-Diagnostics sector is Healthcare.
Co-Diagnostics CODX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
146.53 USD — |
-0.75
|
— — | 144.14 USD — | 148.72 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}